Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.00
-0.20 (-3.23%)
At close: Apr 17, 2025, 4:00 PM
6.00
0.00 (0.00%)
After-hours: Apr 17, 2025, 5:14 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novavax stock have an average target of 17.83, with a low estimate of 9.00 and a high estimate of 26. The average target predicts an increase of 197.17% from the current stock price of 6.00.
Analyst Consensus: Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for Novavax stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +216.67% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +216.67% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +216.67% | Nov 12, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +316.67% | Oct 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $23 → $26 | Strong Buy | Reiterates | $23 → $26 | +333.33% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
689.47M
from 682.16M
Increased by 1.07%
Revenue Next Year
538.62M
from 689.47M
Decreased by -21.88%
EPS This Year
0.09
from -1.23
EPS Next Year
0.71
from 0.09
Increased by 709.30%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 933.0M | 482.6M | ||
| Avg | 689.5M | 538.6M | 324.4M | ||
| Low | 318.5M | 314.2M | 161.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 75.0% | 35.3% | -10.4% | ||
| Avg | 1.1% | -21.9% | -39.8% | ||
| Low | -53.3% | -54.4% | -70.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.95 | 2.61 | 1.02 | ||
| Avg | 0.09 | 0.71 | 0.04 | ||
| Low | -1.27 | -1.13 | -0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 2,880.5% | 43.5% | ||
| Avg | - | 709.3% | -94.6% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.